- Home
- GLDG vs DERM Comparison
GLDG vs DERM Comparison
Compare GLDG & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- DERM
- Stock Information
- Founded
- GLDG 2009
- DERM 2014
- Country
- GLDG Canada
- DERM United States
- Employees
- GLDG N/A
- DERM N/A
- Industry
- GLDG Precious Metals
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- GLDG Basic Materials
- DERM Health Care
- Exchange
- GLDG Nasdaq
- DERM Nasdaq
- Market Cap
- GLDG 152.8M
- DERM 181.0M
- IPO Year
- GLDG N/A
- DERM 2021
- Fundamental
- Price
- GLDG $0.72
- DERM $7.04
- Analyst Decision
- GLDG Strong Buy
- DERM Strong Buy
- Analyst Count
- GLDG 1
- DERM 2
- Target Price
- GLDG $3.25
- DERM $10.00
- AVG Volume (30 Days)
- GLDG 609.8K
- DERM 176.7K
- Earning Date
- GLDG 07-15-2025
- DERM 08-11-2025
- Dividend Yield
- GLDG N/A
- DERM N/A
- EPS Growth
- GLDG N/A
- DERM N/A
- EPS
- GLDG N/A
- DERM N/A
- Revenue
- GLDG N/A
- DERM $56,243,000.00
- Revenue This Year
- GLDG N/A
- DERM $28.99
- Revenue Next Year
- GLDG N/A
- DERM $52.61
- P/E Ratio
- GLDG N/A
- DERM N/A
- Revenue Growth
- GLDG N/A
- DERM N/A
- 52 Week Low
- GLDG $0.71
- DERM $3.54
- 52 Week High
- GLDG $1.06
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- GLDG 41.15
- DERM 51.51
- Support Level
- GLDG $0.73
- DERM $6.22
- Resistance Level
- GLDG $0.78
- DERM $7.28
- Average True Range (ATR)
- GLDG 0.02
- DERM 0.37
- MACD
- GLDG -0.00
- DERM 0.03
- Stochastic Oscillator
- GLDG 7.36
- DERM 77.58
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.